Last update 01 Nov 2024

Canopus Holding SA

Holding Company|
1971|
Brazil
|
www.canopus.com.br

Overview

Related

7
Drugs associated with Canopus Holding SA
Oltipraz
Target
Nrf2
Mechanism
Nrf2 stimulants
Active Org.
University of PennsylvaniaUniversity of Pennsylvania
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Colonic Cancer
Inactive Indication
Liver Cirrhosis [+2]
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date-
Mogroside IV
Target
TLR
Mechanism
TLR agonists
Active Org.-
Originator Org.
Canopus Holding SA
Active Indication-
Inactive Indication
Dengue [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
CB-1922
Target
Aldosterone
Mechanism
Aldosterone antagonists
Active Org.-
Originator Org.
Canopus Holding SA
Active Indication-
Inactive Indication
HIV Infections
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
100 Clinical Results associated with Canopus Holding SA
Login to view more data
0 Patents (Medical) associated with Canopus Holding SA
Login to view more data
100 Deals associated with Canopus Holding SA
Login to view more data
100 Translational Medicine associated with Canopus Holding SA
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 25 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
7
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Oltipraz
 ( Nrf2 )		Nonalcoholic Steatohepatitis
More
Discontinued
CB-2009
 ( CRHR1 )		Hepatitis C
More
Discontinued
CB-3900
Bacterial Infections
More
Discontinued
Mogroside IV
 ( TLR )		Hepatitis C
More
Discontinued
CB-1922
 ( Aldosterone )		HIV Infections
More
Discontinued
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free